Moderna's Altra Score Jumps to Bullish

Moderna (MRNA) recently captured attention with a substantial shift in its momentum profile, as its Altra Score transitioned from 57.2 (Neutral) to 75.4 (Bullish) on July 14. This impressive 18.2-point surge in a single day raises a key question for active investors and traders: Does this represent the beginning of a sustained upward trend, or is it a more isolated burst of strength?

The Altra Score, a proprietary 0-100 momentum score for individual stocks, synthesizes EMA alignment and RSI trends across daily, weekly, and monthly timeframes. A higher score, such as Moderna's current 75.4, indicates increasingly bullish momentum. Upon closer inspection of Moderna's technicals, several factors align with this positive shift. The stock is currently trading above its key Exponential Moving Averages (EMAs), a classic bullish signal indicating that short-term price action is outperforming its longer-term averages. Furthermore, a bullish Weekly EMA Crossover, recorded on January 2, 2026, laid a longer-term foundation for upward momentum.

Looking at the Relative Strength Index (RSI), a popular oscillator that measures the speed and change of price movements, Moderna displays robust readings on longer timeframes. Its weekly RSI stands at 62.89, with the monthly RSI even stronger at 76.66. These figures suggest significant buying pressure and conviction over medium to long-term horizons, which often underpins more durable trends. However, the daily RSI at 53.7 is more neutral, indicating that the immediate short-term trend, while positive, may not yet be showing the same intensity as the longer timeframes.

While Moderna's individual momentum is undeniable, understanding its context requires examining the broader market and sector landscapes. The USHEALTHCARE sector, where Moderna resides, currently holds an Altra Sector score of 65.0. This score, which assesses momentum at the sector level and ranks it against others, places USHEALTHCARE at rank 3, but still within a "bearish" regime. This suggests that despite being a relatively strong performer among its peers, the sector as a whole continues to face headwinds. The sector's regime detail indicates it is "still lagging, but starting to turn up," with a 4-week Relative Strength trend of +0.05 and an RS RSI of 51.2, showing nascent signs of improvement but not yet a decisive turn.

On the market front, the overall US market, as measured by the Altra Market score, sits at 58.3, signaling an "Improving" market texture. The Altra Market score gauges market breadth by looking at the percentage of stocks above key EMAs. Current breadth figures show 55.27% of stocks above their 20-day EMA, 61.63% above their 50-day EMA, and 65.41% above their 200-day EMA. The 15-day score trend is positive, up by 1.8 points. However, the market's internal dynamics show 200 advances against 303 declines, indicating that while overall breadth may be improving, a larger number of individual stocks are still seeing downward pressure on any given day. This aligns with the market's current guidance to "Be selective — favor high-quality setups."

This confluence of factors presents a nuanced picture for Moderna. The stock's significant Altra Score increase and strong longer-term RSI readings point to genuine internal strength. Yet, the fact that Moderna is not yet "top-down aligned" (meaning its momentum across all timeframes isn't uniformly bullish) and operates within a still-struggling sector warrants careful consideration. While the market environment is improving, the advice to be selective is particularly relevant here. Moderna's move to a "Bullish" Altra Score is certainly a notable development, but its sustainability will likely depend on its ability to either drive its sector higher or continue to demonstrate exceptional relative strength in a challenging environment.

What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.

Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.

Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.